The recommended dose of Lupifil-P (pegfilgrastim) is a single subcutaneous injection of 6 mg administered once per chemotherapy cycle in adults. Lupifil-P (pegfilgrastim) should not be administered between 14 days before and 24 hours after administration of cytotoxic chemotherapy.
Prior to administration visually inspect parenteral drug products for particulate matter and discoloration. Do not administer Lupifil-P (pegfilgrastim) if discoloration or particulates are observed.
Sign Out